Neuroprotectives: Herbs vs Heterocyclics

  • Divya Dhawal Bhandari University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh
  • Prabhjot Kaur RIMT University
  • Hitesh Chopra Department of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai - 602105, Tamil Nadu, India
  • Suman Lata ASBASJSM College of Pharmacy, Bela
DOI: https://doi.org/10.5937/scriptamed56-54299
Keywords: Central nervous system, Peripheral nervous system, Herbal medicine, Parkinson disease, Multiple sclerosis

Abstract


Neurodegenerative diseases are described as the ones associated with the loss of any specific nerve function which results in either cell death or abnormal functioning of associated organ such as memory loss, tremors, difficulty in speaking and walking, loss of senses and numbness. A number of heterocyclic nuclei containing compounds are available in the market to treat neurodegenerative disorders and associated symptoms due to their concerned therapeutic potential. Ongoing research on these heterocyclics have confirmed their tremendous potential towards the treatment of neurodegenerative diseases. Although a number of heterocyclic containing compounds are already there in the market against various neurodegenerative diseases, but till date no specific treatment is available against any of the neurodegenerative disease, thus opening new area of research. Herbs are emerging as new area of research due to their wide availability and with lesser or no side effects. These days researchers are gaining interest towards the development of newer neurodegenerative agents derived from plants. This review is focused towards the comparison of various available herbs, heterocyclics and the compounds under clinical trials, against neurodegenerative diseases primarily focusing on Parkinson disease and multiple sclerosis.

References

Hiremathad A, Piemontese L. Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy. Neural Regen Res. 2017 Aug;12(8):1256-61. doi: 10.4103/1673-5374.213541.

Rizzi G, Tan RK. Dopamine and Acetylcholine, A circuit point of view in Parkinson’s disease. Front. Neural Circuits. 2017 Dec 22;11:110. doi: 10.3389/fncir.2017.00110.

Delenclos M, Jones DR, McLean PJ, Uitti RJ. Biomarkers in Parkinson's disease: Advances and strategies. Parkinsonism Relat Disord. 2016 Jan; 22 Suppl 1(Suppl 1):S106-S110. doi: 10.1016/j.parkreldis.2015.09.048.

Kaur P, Sodhi RK. Memory recuperative potential of rifampicin in aluminum chloride-induced dementia: role of pregnane X receptors. Neuroscience. 2015 Mar;288:24-36. doi: 10.1016/j.neuroscience.2014.12.033.

Garg N, Smith TW. An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav. 2015 Sep;5(9):e00362. doi: 10.1002/brb3.362.

Anandhan K, Tamilselvam T, Radhiga S, Rao MM, Essa TM. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Brain Res. 2012 Jan 18; 1433: 104–113. doi: 10.1016/j.brainres.2011.11.021.

Huang X, Li N, Pu Y, Zhang T, Wang B. Neuroprotective effects of Ginseng phytochemicals: recent perspectives. Molecules. 2019 Aug 14;24(16):2939. doi: 10.3390/molecules24162939.

Le Witt PA, Fahn S. Levodopa therapy for Parkinson disease a look backward and forward. Neurology. 2016 Apr 5;86:S3–S12. doi: 10.1212/WNL.0000000000002509.

Zbarsky V, Datla KV, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res. 2005 Oct;39:1119–25. doi: 10.1080/10715760500233113.

Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics. 2019 July;16:666-74. doi: 10.1007/s13311-019-00767-8.

Liu SM, Li XZ, Huo Y, Lu F. Protective effect of extract of Acanthopanax senticosus harms on dopaminergic neurons in Parkinson's disease mice. Phytomedicine. 2012 May 15;19(7):631-8. doi: 10.1016/j.phymed.2012.02.006.

Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M. Oxidative stress and Parkinson’s disease: new hopes in treatment with herbal antioxidants. Curr Pharm Des. 2016;22(2):238-46. doi: 10.2174/1381612822666151112151653.

Fujikawa T, Kanada N, Shimada A, Ogata M, Suzuki I, Hayashi I, et al. Effect of sesamin in Acanthopanax senticosus H ARMS on behavioral dysfunction in rotenone-induced parkinsonian rats. Biol Pharm Bull. 2005 Jan;28(1):169-72. doi: 10.1248/bpb.28.169.

Beppe GJ, Dongmo AB, Foyet HS, Dimo T, Mihasan M, Hritcu, L. The aqueous extract of Albizia adianthifolia leaves attenuates 6-hydroxydopamine-induced anxiety, depression and oxidative stress in rat amygdala. BMC Complement Altern Med. 2015 Oct 19;15(1):1-13. doi: 10.1186/s12906-015-0912-0.

Banu Z, Fatima SJ, Fatima A, Fatima S, Zohra SF, Sultana T. Phytochemical evaluation and pharmacological screening of Antiparkinson’s activity of allium sativum in Swiss/Albino Mice. IOSRPHR. 2016 Jun;6(6):1-12.

Garcia E, Santana-Martinez R, Silva-Islas CA, Colin-Gonzalez AL, Galvan-Arzate S, Heras Y, Santamaria A. S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: participation of Nrf2. Free Radic Res. 2014 Feb;48(2):159-67. doi: 10.3109/10715762.2013.857019.

Zhang ZJ, Cheang LC, Wang MW, Li GH, Chu IK, Lin ZX et. al. Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Cell Mol Neurobiol. 2012 Jan;32(1):27–40. doi: 10.1007/s10571-011-9731-0.

Zhang HN, An CN, Zhang HN, Pu XP. Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo. Neurosci Lett. 2010 Apr;474(2):99-103. doi: 10.1016/j.neulet.2010.03.016.

Shinomol GK, Mythri RB, Srinivas Bharath MM. Bacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brain. Cell mol neurobiol. 2012 Apr;32(3):455-65. doi: 10.1007/s10571-011-9776-0.

Magnnavar CV, Avinash SP, Sowmya C. Neuroprotective Activity of Berberis aristata against 6‐OHDA Induced Parkinson's Disease Model. FASEBJ. 2013 Apr;890-16. doi: 10.1096/fasebj.27.1_supplement.890.16.

Nade VS, Kawale LA, Zambre SS, Kapure AB. Neuroprotective potential of Beta vulgaris L. in Parkinson's disease. Indian J Pharmacol. 2015 Jul-Aug; 47(4):403. doi: 10.4103/0253-7613.161263.

Prasanth MI, Sivamaruthi BS, Chaiyasut C, Tencomnao T. A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy. Nutrients. 2019 Feb 23;11(2):474. doi: 10.3390/nu11020474.

Ren R, Shi C, Cao J, Sun Y, Zhao X, Guo Y et. Al. Neuroprotective effects of a standardized flavonoid extract of safflower against neurotoxin-induced cellular and animal models of Parkinson's disease. Sci Rep. 2016 Feb 24;6:22135. doi: 10.1038/srep22135.

Ju MS, Kim HG, Choi JG, Ryu JH, Hur J, Kim YJ et.al. Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models. Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2037-44. doi: 10.1016/j.fct.2010.05.002.

Bagewadi HG, Khan AK. Evaluation of anti-parkinsonian activity of Elaeocarpus ganitrus on haloperidol induced Parkinson’s disease in mice. Int J Basic Clin Pharmacol. 2015 Jan 20; 4(1):102–6. doi: 10.5455/2319-2003.ijbcp20150218.

Auddy B, Ferreira M, Blasina F, Lafon L, Arredondo F, Dajas F, et.al. Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases. J Ethnopharmacol. 2003 Feb;84(2-3):131-8. doi: 10.1016/s0378-8741(02)00322-7.

Alam G, Edler M, Burchfield S, Richardson JR. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss. Neurotoxicology. 2017 May;60:99-106. doi: 10.1016/j.neuro.2017.03.008.

Zou YP, Lu YH, Wei DZ. Protective effects of a flavonoid-rich extract of Hypericum perforatum L. against hydrogen peroxide-induced apoptosis in PC12 cells. Phytother Res. 2010 Jan;24 Suppl 1:S6-S10. doi: 10.1002/ptr.2852.

Kang X, Chen J, Xu Z, Li H, Wang B. Protective effects of Ginkgo biloba extract on paraquat-induced apoptosis of PC12 cells. Toxicol In Vitro. 2007 Sep;21(6):1003-9. doi: 10.1016/j.tiv.2007.02.004.

Muroyama A, Fujita A, Lv C, Kobayashi S, Fukuyama Y, Mitsumoto Y. Magnolol protects against MPTP/MPP(+)-induced toxicity via inhibition of oxidative stress in in vivo and in vitro models of Parkinson's disease. Parkinsons Dis. 2012;2012:985157. doi: 10.1155/2012/985157.

Kim HG, Ju MS, Shim JS, Kim MC, Lee SH, Huh Y, et al. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models. Br J Nutr. 2010 Jul;104(1):8-16. doi: 10.1017/S0007114510000218.

Cao BY, Yang YP, Luo WF, Mao CJ, Han R, Sun X et.al. Paeoniflorin, a potent natural compound, protects PC12 cells from MPP+ and acidic damage via autophagic pathway. J Ethnopharmacol. 2010 Aug 19;131(1):122-9. doi: 10.1016/j.jep.2010.06.009.

Hu S, Han R, Mak S, Han Y. Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells. J Ethnopharmacol. 2011 Apr 26;135(1):34-42. doi: 10.1016/j.jep.2011.02.017.

Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 2000 Aug;5(4):334-46. PMID: 10956379.

Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int. 1997 Feb;30(2):181-90. doi: 10.1016/s0197-0186(96)00025-3.

Nagashayana N, Sankarankutty P, Nampoothiri MR, Mohan PK, Mohanakumar KP. Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease. J Neurol Sci. 2000 Jun 15;176(2):124-7. doi: 10.1016/s0022-510x(00)00329-4.

Huang X, Li N, Pu Y, Zhang T, Wang B. Neuroprotective effects of ginseng phytochemicals: recent perspectives. Molecules. 2019 Aug 14;24(16):2939. doi: 10.3390/molecules24162939.

Lü JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009 Jul;7(3):293-302. doi: 10.2174/157016109788340767.

Ju MS, Lee P, Kim HG, Lee KY, Hur J, Cho SH et.al. Protective effects of standardized Thuja orientalis leaves against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. Toxicol In Vitro. 2010 Apr;24(3):759-65. doi: 10.1016/j.tiv.2009.12.026.

Kosaraju J, Chinni S, Roy PD, Kannan E, Antony AS, Kumar MN. Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism. Indian J Pharmacol. 2014 Mar-Apr;46(2):176-80. doi: 10.4103/0253-7613.129312.

Shim JS, Kim HG, Ju MS, Choi JG, Jeong SY, Oh MS. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease. J Ethnopharmacol. 2009 Nov 12;126(2):361-5. doi: 10.1016/j.jep.2009.08.023.

Hiremathad A, Piemontese L. Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy. Neural Regen Res. 2017 Aug;12(8):1256-61. doi: 10.4103/1673-5374.213541.

Brahmachari S, Pahan K. Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis. J Immunol. 2007 Jul 1;179(1):275-83. doi: 10.4049/jimmunol.179.1.275.

Prakash J, Chouhan S, Yadav SK, Westfall S, Rai SN, Singh SP. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem Res. 2014 Dec;39(12):2527-36. doi: 10.1007/s11064-014-1443-7.

Kaur P, Sharma V. Prospective plant based anticancer lead molecules. Curr Top Med Chem. 2018;18(30):2567-83. doi: 10.2174/1568026619666181224101132.

Nematollahi M, Majdinasab N, Fakharzade L, Namjooyan F, Latifi S, Pouretezad M. The effect of Nigella sativa seeds on the muscle spasticity of lower limbs in patients with multiple sclerosis. Iran J Neurol. 2013;12:16. doi: 10.4103/2225-4110.136543.

Published
2025/06/30
Issue
Vol. 56 No. 3 (2025): May-Jun
Section
Current topic
Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).